The weekly litigation news digest is live. Subscribe now

IP Verse

Pseudopolymorphic Forms Of A Hiv Protease Inhibitor - EP2767539

The patent EP2767539 was granted to Janssen R&D Ireland on Jul 12, 2017. The application was originally filed on May 16, 2003 under application number EP14168686A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2767539

JANSSEN R&D IRELAND
Application Number
EP14168686A
Filing Date
May 16, 2003
Status
Opposition Rejected
Feb 10, 2023
Publication Date
Jul 12, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

COOKEApr 12, 2018ELKINGTON AND FIFEADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0715618
DESCRIPTIONUS6248775
DESCRIPTIONWO9967417
OPPOSITIONUS6248775
OPPOSITIONWO03106461
OPPOSITIONWO9506030
OPPOSITIONWO9967417
SEARCHWO9506030
SEARCHWO9967417

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents